Our Stocks to Watch today include Organa Gardens International Inc. (OTCBB: OGNG), Waytronx Inc. (OTCBB: WYNX), China Youth Media Inc. (OTCBB: CHYU), NavStar Technologies Inc. (OTC: NVSR), Access Pharmaceuticals Inc. (OTCBB: ACCP), Green Star Alternative Energy Inc. (OTC: GSAE), SGD Holdings Ltd. (OTC: SGDH), Encorium Group Inc. (Nasdaq: ENCO), Zcom Networks Inc. (OTC: ZCNW), Alloy Steel International Inc. (OTCBB: AYSI), Cardiac Network Inc. (OTC: CNWI) and SymPowerco Corp. (OTC: SYMW).
Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover’s Digest Newsletter and Email Stock Watch Alerts.
ORGANA GARDENS INTERNATIONAL INCORPORATED (OTCBB: OGNG)
"Up 36.11% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/OGNG.php
Company Profile: http://www.otcpicks.com/Newsletter/OGNA_NA_090909.html
Organa Gardens International Inc. has a vertical hydroponics farming system built to make the most efficient use of light, energy, water, land, temperature and production cycle while growing the highest quality and healthiest plants in an optimum, consistent environment unaffected by weather. The Organa Garden Systems (OGS) provide a means for food production and consumption change to global environmental and ecological sustainability through vertical hydroponics rotary farming.
OGNG News:
September 9 - Organa's OGS-E Is Ready for Global Use
Organa Gardens International Inc. (OTCBB: OGNG) reports that the Company's completed proto-type Organa Garden Systems OGS-E (
Organa is now confident that it can now bring the OGS-E to commercialization. The Company feels that its protocol will grow the safest produce you can buy and it will be a significant participant in the fast growing hydroponic organic market.
In May 2009, Organic Trade Association released results of their 2008 Manufacturers survey. This is an annual survey to track the sales and growth of organic food and other organic products. In 2008 the sales of organic food grew 15.8% to reach $22.9 billion in the
In
The
WAYTRONX INCORPORATED (OTCBB: WYNX)
Detailed Quote: http://www.otcpicks.com/quotes/WYNX.php
Company Profile: http://www.otcpicks.com/waytronx.htm
Waytronx, Inc. has pioneered and is developing innovative thermal management solutions capable of revolutionizing the semiconductor, solar and electronic packaging industries, among others, utilizing its patented WayCool™/WayFast™ hybrid mesh architecture. In addition, through its acquisition of CUI in May 2008, Waytronx has developed the infrastructure, expertise, and platform necessary to acquire, develop, and commercialize new, innovative technologies. Waytronx changed its name from OnScreen Technologies in December 2007.
WYNX News:
September 3 - Waytronx, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference
Waytronx, Inc. (OTCBB: WYNX), a leading provider of openly licensable advanced systems cooling solutions, announced today that the Company will present at the upcoming Rodman & Renshaw Annual Global Investment Conference to be held on September 9-11 at the New York Palace Hotel in New York City.
The Rodman & Renshaw Annual Global Investment Conference is a three-day event which features tracks devoted to Healthcare, Metals & Mining, Energy, Clean-tech, Asia, Community & Regional Banks, Growth, & Maritime. So far, more than 500 companies have registered to attend the conference. Schedule of Waytronx's presentation is as follows:
Date: Friday, September 11, 2009
Time: 10:50 a.m. Eastern Time
Venue:
New York Palace Hotel
Interested investors may access a live broadcast of the presentation through the event website at www.wsw.com/webcast/rrshq15/wynx.ob.
During the conference, the Company will be available for one-on-one meetings.
ABOUT CUI, INC.
CUI, Inc. is a solutions provider of electromechanical components and industrial controls for OEM manufacturing. Since its inception in 1989, CUI has been delivering quality products, extensive application solutions, and superior personal service. CUI's solid customer commitment and honest corporate message are a hallmark in the industry. CUI is a wholly-owned subsidiary of Waytronx, Inc.
ABOUT RODMAN & RENSHAW CAPITAL GROUP, INC.
Rodman & Renshaw Capital Group, Inc. is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC.
Rodman & Renshaw, LLC is a full service investment bank dedicated to providing investment banking services to companies that have significant capital needs, along with research and sales and trading services to investor clients that focus on such companies. Rodman is a leading investment banking firm with particular emphasis on industries with significant capital needs, including health care, energy, and metals/mining, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
"Up 16.67% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CHYU.php
Company Profile: http://www.otcpicks.com/china-youth-media/china-youth-media.htm
China Youth Media, Inc. is a China-focused youth marketing and media company whose business is to deliver advertising and content to one of the most sought after and fastest growing demographics in the world. Through its wholly owned subsidiary Youth Media (Hong Kong) Limited, CHYU has secured contracts with a term of 20 plus 10 years that provide exclusive rights from the Chinese government controlled corporation, China Youth Interactive, which uniquely position CHYU to market to China’s massive student population with preferred access online, on campus and on mobile. CHYU currently targets
CHYU News:
September 9 -
China Youth Media, Inc. (OTCBB: CHYU), a China focused youth marketing and media company, announced that its Koobee Network has launched an advertising campaign for the athletic footwear company Converse, a subsidiary of the world’s leading athletic shoes and apparel company, Nike.
Koobee, China Youth Media’s Intranet Television Network and media portal, delivers TV-quality content and advertising directly to China’s 30 million plus college students on a dedicated network targeted to campuses nationwide. The Converse ad campaign is running on Koobee’s recently launched MOGO Music Channel. Produced for and targeted specifically to
“We are very pleased to launch the Converse campaign on Koobee and expect it to become one of many to generate ad revenue for the company,” commented Jay Rifkin, China Youth Media’s CEO. “As more campaigns like this are sold, we believe that Koobee’s highly targeted youth platform will become premium ad inventory for major global brands.”
NAVSTAR TECHNOLOGIES INCORPORATED (OTC: NVSR)
Detailed Quote: http://www.otcpicks.com/quotes/NVSR.php
Company Profile: http://www.otcpicks.com/navstar-technologies/navstar-technologies.htm
NavStar is focused on the creation of GPS products and services that provide wireless tracking of vehicles, equipment, and other valuable and personal assets. The goal is to be a total solutions provider.
NVSR News:
September 9 - NavStar Technologies, Inc. to Pay 10% Stock Dividend
NavStar Technologies, Inc. (OTC: NVSR) announces that the Company's Board of Directors has authorized a 10% (ten percent) dividend of the Company's Common Stock for its Stockholders of Record as of Wednesday, September 30, 2009. The Stock Dividend Pay Date to stockholders will be on Wednesday, October 14, 2009.
The Company elected to reward those stockholders who had remained loyal to the Company and have been patient as 2009 has unfolded slower than expected. Each holder with 100 shares of NavStar Technologies, Inc. common stock as of September 30, 2009 shall be entitled to receive ten (10) additional shares of common stock. For example, if a holder owns a round lot of 500 shares he or she shall receive 50 additional shares. The payment date for the common stock dividend is set for October 14, 2009.
This Stock Dividend will be electronically credited to stockholders' accounts on the Pay Date. Those stockholders who are not holding their shares with Brokers will receive their Stock Dividends in certificated form.
ACCESS PHARMACEUTICALS INCORPORATED (OTCBB: ACCP)
Detailed Quote: http://www.otcpicks.com/quotes/ACCP.php
Company Profile: http://www.otcpicks.com/access-pharmaceuticals/access-pharmaceuticals.htm
Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes propriety products for the treatment and supportive care of cancer patients. Access' products include ProLindac™, currently in Phase 2 clinical testing of patients with ovarian cancer, and MuGard™ for the management of patients with mucositis. The company also has other advanced drug delivery technologies including Cobalamin™-mediated targeted delivery and oral drug delivery, its proprietary nanopolymer delivery technology based on the natural vitamin B12 uptake mechanism; Angiolix®, a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine, a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers.
ACCP News:
September 1 - Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
Access to Provide Update on MuGard Global Commercial Launch and ProLindac Clinical Development Plans
Access Pharmaceuticals, Inc. (OTCBB: ACCP) announced that Access will present at the Rodman & Renshaw 11th Annual Healthcare Conference to be held September 9-11, 2009 at the New York Palace Hotel in New York City. Jeffrey B. Davis, President and CEO of Access is scheduled to speak on Friday, September 11, 2009 at 10:50 am EDT in the Fahnestock Salon (5th Floor) and will give a corporate overview and discuss the Company's product opportunities.
Visit www.wsw.com/webcast/rrshq15/accp.ob to view the presentation. A replay can be obtained at the same link for up to 90 days after the live presentation.
ABOUT MUGARD
MuGard is a novel, ready-to-use mucoadhesive oral wound rinse for the management of oral mucositis, a debilitating side effect of many anticancer treatments. Up to 40% of all patients receiving chemotherapy and/or radiotherapy develop moderate to severe mucositis, and almost all patients receiving radiotherapy for head and neck cancer and those undergoing stem cell transplantation develop mucositis. Updated clinical practice guidelines for the prevention and treatment of mucositis recommend the use of a preventive oral care regimen as part of routine supportive care along with a therapeutic oral care regimen if mucositis develops. The market for the treatment of oral mucositis, used prophylactically for patients undergoing chemotherapy and radiation therapy, is estimated to be in excess of $5 billion world-wide.
ABOUT PROLINDAC™
ProLindac is a novel DACH platinum prodrug which has been shown to be active in a wide variety of solid tumors in both preclinical models and in human trials. Access believes that ProLindac's unique molecular design potentially could eliminate some of the toxic side effects seen in the currently marketed DACH platinum, Eloxatin, which has sales in excess of $2 billion. Access has previously announced that it has licensed ProLindac to Aosaikang Medicinal Group ("ASK") for the Greater China Region and to JCOM, Ltd for
GREEN STAR ALTERNATIVE ENERGY INCORPORATED (OTC: GSAE)
Detailed Quote: www.otcpicks.com/quotes/GSAE.php
Company Profile: http://www.otcpicks.com/Newsletter/GSAE_eProfile_091708.htm
Green Star Alternative Energy is an environmentally conscious, renewable energy producer. The Company is working to develop more than 300 MW (megawatts) of clean electricity through wind energy. The corporate revenue model is two-fold: the use of a renewable resource allows not only for the creation of environmentally friendly energy, but the granting of carbon (greenhouse gas) emission credits which may be traded and sold. Green Star is pursuing a significant opportunity to provide clean energy to the growing
GSAE News:
August 27 - A New Audio Interview with Mike Andric, CEO of Green Star Alternative Energy, Inc., is Now at SmallCapVoice.com
SmallCapVoice.com, Inc. announced that a new audio interview with Green Star Alternative Energy, Inc. (OTC: GSAE) is now available. The interview can be heard at http://smallcapvoice.com/blog/8-26-09-audio-interview-with-green-star-alternative-energy-inc-otcpk-gsae.
SGD HOLDINGS LIMITED (OTC: SGDH)
"Up 2.86% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SGDH.php
Company Profile: http://www.otcpicks.com/sgd-holdings/sgd-holdings.htm
SGD Holdings, Ltd. is a holding company which owns and operates through its wholly-owned subsidiary, Ecopaper, Inc. (www.ecopaper.com). Its goal is to acquire new technologies which can positively impact the environment either through internal development or by acquisition.
SGDH News:
September 2 - SGD Holdings, Ltd. Sees Higher Demand Forecast for Fiscal 2010
Numerous domestic and international business inquiries regarding both treeless bulk and office paper products may add significantly to sales at Ecopaper, SGD Holdings, Ltd.'s (OTC: SGDH) wholly-owned subsidiary for the next calendar year.
"We anticipate increasing the production of our treeless bulk and office paper products by as much as 40% if current business contacts result in actual orders," stated Harry Johansing, CEO of SGD Holdings, Ltd. "I am confident that the current level of interest will materialize into significantly higher sales for fiscal 2010. While lower margins can be expected on bulk paper product sales, the actual sales volume should be significantly higher than our original forecast for fiscal 2010," he concluded.
ABOUT ECOPAPER, INC.
Ecopaper, Inc. is the first company in the history of the paper industry to create and market treeless paper of a superior quality. Every page of Ecopaper is smooth, acid-free, durable, chemical-free, and made in
ENCORIUM GROUP INCORPORATED (NASDAQ: ENCO)
"Up 308.48% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ENCO.php
Encorium Group, Inc. is a global clinical research organization specializing in the design and management of complex clinical trials and Patient Registries for the pharmaceutical, biotechnology and medical device industries. The Company's mission is to provide its clients with high quality, full-service support for their biopharmaceutical and medical device development programs. Encorium offers therapeutic expertise, experienced team management and advanced technologies. The Company has drug and biologics development as well as clinical trial experience across a wide variety of therapeutic areas such as infectious diseases, cardiovascular, vaccines, oncology, diabetes endocrinology/metabolism, gene therapy, immunology, neurology, gastroenterology, dermatology, hepatology, women's health and respiratory medicine. Encorium believes that its expertise in the design of complex clinical trials, its therapeutic experience and commitment to excellence, and its application of innovative technologies, offer its clients a means to more quickly and cost effectively move products through the clinical development process.
ENCO News:
September 8 - Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win
Company Successful with its Strategic Focus on Vaccines and Oncology Trials
Encorium Group, Inc. (Nasdaq: ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceutical companies, today announced the signing of approximately $8.7 million of new business contracts, including selection by a major pharmaceutical company for participation in a swine flu vaccine program.
Dr. Kai Lindevall, executive chairman stated, "We are delighted to be able to announce these new business awards, despite a very challenging market environment. Our experience and capabilities in the vaccine field have been of paramount importance in our success. We are very proud of being the selected partner for one of the frontline clinical development programs for the swine flu vaccine. In addition, we were also recently entrusted with a avian flue vaccine, as well as other vaccine development programs having, in the aggregate, approximately 12,000 patient subjects. We believe our participation in these studies exemplifies the level of trust and respect that large vaccine companies have in our vaccine expertise and clinical operations.
"We believe Encorium has developed into one of the strongest medium sized clinical research organizations with expertise in the field of clinical vaccine development. Our recent success in the vaccine field has been substantial, with revenues from vaccine trials increasing by 150% in 2009 versus 2008. As an acknowledgement of our achievements, in April 2009, Encorium was nominated as a finalist for the Second Annual Vaccine Industry Excellence Award.
"The establishment of our Core Vaccine Team has made it possible to enter strategic partnerships with a number of clients. Moving forward, our goal is to grow into the world's leading vaccine franchise and to create a vertical niche expertise in the field of vaccine research, covering pre-clinical support, regulatory consultancy and strategic trial planning. As an integral part of this strategy, the Company has began and plans to continue creating global investigator and clinic networks to strengthen the Company's ability to conduct large scale global phase III vaccine trials. Through these networks it will be possible for us to achieve fast and efficient subject/patient recruitment for vaccine trials globally, which will also ensure a strong local ownership and a strong ethical foundation.
"The Company has also been successful in winning trials in the field of oncology during 2009. Thus far in 2009, Oncology trials constitute the second largest revenue generating therapeutic field after vaccines. We believe our vaccine experience will continue to assist us in gaining new contract wins in the oncology sector, as we will continue to focus, not just on prophylactic vaccines, but also on therapeutic vaccines, which constitute a substantial number of oncology trials and are the fastest growing area within vaccine development. Based on our expertise and success in the field of vaccines and oncology, we believe we are well positioned to further strengthen our market position in these niche areas."
The new business awards announced today mitigate any negative impact to our backlog as reported at June 30, 2009 from foreign currency translations, contract amendments and terminations and revenue recognized. The Company had reported consolidated backlog at June 30, 2009 from continuing operations of $19.6 million which compared to a backlog of $23.5 million at June 30, 2008.
ZCOM NETWORKS INCORPORATED (OTC: ZCNW)
"Up 50.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/ZCNW.php
Zcom is a multi-industry company with two core businesses: Media Broadcasting/Home Shopping Division and Mineral rights/Real Estate Division. Zcom offers radio and video content delivered live and on demand over the internet. Audiences can access programs 24 hours a day, seven days a week, directly or via podcast. The company is in the process of launching a Direct Broadcast Satellite (DBS) and IP TV broadcast that will reach over 10 million households in the US, Canada and Mexico. Zcom also offers products and services through its Home Shopping Network marketed and promoted through the company's TV/IP TV broadcast resources and through its affiliate network. Existing products/services include Super Fuel and TV Box. Zcom's Mineral Rights/Real Estate Division owns a mining development, exploration and extraction company with a 160 acre gold, silver, tungsten, platinum and copper placer mining claim -- CLS #12 in
ZCNW News:
September 9 - Zcom Networks Acquires Balance of Shares Of Speedia Media
Zcom Networks, Inc. (OTC: ZCNW) announced that it has acquired the balance of shares of Speedia Media, Inc. from SNN, Inc. which will make Speedia Media, Inc. a wholly owned subsidiary of Zcom.. Speedia Media, Inc. is the owner of "Talk Money TV" (www.talkmoneytv.com).
"'Talk Money TV' is positioned to become one of the most innovative financial/business channels by providing a platform for CEOs and entrepreneurs to present their message as well as their products and services. 'Talk Money TV' is one of the most concise and audience focused channels by providing financial, economic, and general business information highlighting Micro-Cap companies with live and pre-recorded content," said Dr. Alex Parsinia, CEO of Zcom. "Talk Money TV" shows are broadcast through satellite and cable.
ALLOY STEEL INTERNATIONAL INCORPORATED (OTCBB: AYSI)
"Up 7.86% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/AYSI.php
Alloy Steel International, Inc., together with its subsidiary, Alloy Steel Australia (Int.) Pty Ltd., engages in the manufacture and distribution of Arcoplate, a wear-resistant alloy overlay wear plate. It offers fused-alloy steel plates for installation and use in structures and machinery that suffer wear and hang-up problems. The company is also developing the 3-D Pipefitting Cladder process. Alloy Steel International's customer base primarily consists of companies involved in the mining and dredging industries in
AYSI News:
September 8 - Alloy Steel International Signs Supply Agreement With BHP Billiton
Mr. Gene Kostecki, Chairman and CEO of Alloy Steel International (OTCBB: AYSI), announced that Alloy Steel Australia (Int) Pty Ltd a wholly owned subsidiary of Alloy Steel International Inc. has signed a long term strategic supply agreement with BHP Billiton to supply Arcoplate Wear Resistant Super Alloy Wearplate for iron ore mining operations in Western Australia.
The initial product taken will be for the multi-million dollar expansion of their operations in the Pilbara area of
Since the announcement in August 2009 of Alloy Steel's successful commissioning, the increased level of interest in the new production mill shown in Arcoplate has been outstanding, according to Mr. Kostecki. Most of the major iron ore miners in
Since commissioning the new Arcoplate mill, it has been working at full capacity satisfying the demand for the new 3/4 inch or 20mm material whilst the other Arcoplate mill has been fully utilized with the ongoing demand for the thinner overlay materials.
As a result of the increased level of interest in Alloy Steel's Arcoplate product by local and international mining companies, the Directors of Alloy Steel are planning for a further two production mills with substantially increased capacity to come on line in early 2010.
CARDIAC NETWORK INCORPORATED (OTC: CNWI)
"Up 16.13% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/CNWI.php
Cardiac Network, Inc. is a medical technology company providing cardiac monitoring and diagnostic services to general practitioners and specialist physicians, for the investigation of patients with abnormal cardiac rhythm and function. The service uses unique transtelephonic (by telephone) cardiac recorders that monitor and provide diagnostic information to physicians and their patients. Cardiac Network also offers its services and advanced mobile technology to individuals which help them quickly determine if they are having potential cardiac problems so that they can obtain immediately needed medical treatment.
CNWI News:
September 8 - Cardiac Network Expands Its Research Study Support With Southern California Permanente Medical Group
Cardiac Network, Inc. (OTC: CNWI) reported that it has expanded the number of sites included in its research study support with Southern California Permanente Medical Group.
Cardiac Network has been providing cardiac monitoring for patients in the study since January 2008. The expanded services allow Cardiac Network to further demonstrate the quality of its monitors, services and cardiograph reports which provide vital data regarding the cardiac health of the patients being monitored. Cardiac Network continues to seek new opportunities to serve the cardiologists and general practitioners that are part of the
ABOUT HEART DISEASE
Cardiovascular diseases (CVD), as defined by the American Heart Association, include coronary heart disease (coronary artery disease); stroke (brain attack); high blood pressure (hypertension); and rheumatic heart disease. About 80 million
ABOUT KAISER PERMANENTE
Kaiser Permanente is
Nationwide, Kaiser Permanente includes approximately 160,000 technical, administrative and clerical employees and caregivers, and more than 11,500 physicians representing all specialties.
SYMPOWERCO CORPORATION (OTC: SYMW)
"Up 20.00% in morning trading"
Detailed Quote: http://www.otcpicks.com/quotes/SYMW.php
SymPowerco Corporation develops advanced fuel cell and power delivery systems for the rapidly growing personal transportation and portable power system markets being created by today's energy and environmental challenges.
SYMW News:
September 9 - SymPowerco Fuel Cell Project Begins
SymPowerco Corporation (OTC: SYMW) CEO John Davenport announced today that the company's Flowing Electrolyte Direct Methanol Fuel Cell Project (FEDMFC) has officially begun at Carleton University in Ottawa, Canada. The Project Team has held its first meeting and has developed and assigned the initial objectives and tasks for the team members, all of whom work within Carleton's Department of Mechanical and Aerospace Engineering.
In addition to refurbishing the SymPowerco 5 Watt FEDMFC prototype and bringing it to operational status, initial tasks for the team include the immediate development of mathematical models that will be used for operational simulations and the assessment of virtual and actual FEDMFC data. The team will also conduct expanded research of related DMFC literature. The Department of Mechanical and Aerospace Engineering has also decided to expand the team to include more graduate students. The FEDMFC project is being funded through a recently announced grant from Ontario Centres of Excellence.
SymPowerco Corporation develops advanced fuel cell and power delivery systems for the rapidly growing personal transportation and portable power system markets that are being created by today's energy and environmental challenges.
OTCPicks.com is located at
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.
Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.
Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov/ and FINRA at http://www.finra.org.
Disclosure: OTCPicks.com has been compensated five thousand dollars by a third party for OGNG advertising and promotional services. OTCPicks.com has been compensated three thousand five hundred dollars by a third party (Level Up Industries) for WYNX advertising and promotional services. OTCPicks.com has been compensated nine thousand five hundred dollars by the company for CHYU advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by a third party (Mickey Reno) for NVSR advertising and promotional services. OTCPicks.com has been compensated three thousand five hundred dollars from a third party (Longview Communications Corp.) for ACCP advertising and promotional services. OTCPicks.com has been compensated eight thousand dollars by the company for GSAE advertising and promotional services. OTCPicks.com has recently been compensated five thousand free trading shares from Onyx Consulting for GSAE advertising and promotion. OTCPicks.com is being compensated eight thousand dollars by a third party (Stock Awareness Group) for SGDH advertising and promotional services. OTCPicks.com has been compensated two thousand five hundred dollars from BlueWave Advisors for CNWI advertising and promotional services. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. OTCPicks.com is a website partially owned by BlueWave Advisors, LLC, a financial public relations firm. BlueWave Advisors, LLC, its principal and/or its affiliates will hold positions in the company profiled and may buy or sell securities at any time without notice.